NRAS and melanoma: In an attempt to search for new compounds that could partner with kinase inhibitors for inhibition of NRAS mutant melanoma [40], we combined α-Mangostin with a series of kinase inhibitors to treat the NRAS mutant melanoma cell line SK-MEL-2.